Ind-Swift Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ind-Swift Laboratories has informed the stock exchanges that its trading window will remain closed starting 1st January, 2026, until 48 hours after the declaration of its Un-Audited Standalone and Consolidated Financial Results for the quarter ended 31st December, 2025 (Q3 FY26). The closure applies to all Promoters, members of the Promoter Group, Directors, Key Managerial Personnel, designated persons, connected persons/insiders, and their immediate relatives, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal insider trading code. During this period, these insiders are prohibited from trading in the company's shares. The intimation was filed by Pardeep Verma, VP-Corporate Affairs & Company Secretary, on 30th December, 2025.
This is a routine regulatory compliance announcement ahead of the Q3 FY26 results and is not expected to impact the stock price. It signals that quarterly results are likely to be declared in mid-to-late January 2026, which investors should watch for.